Latest News & Features
Americas
US research centre the Broad Institute of Massachusetts Institute of Technology and Harvard has entered into a worldwide licensing deal with Editas Medicines, granting it access to IP covering genome technology and human therapeutic applications. 5 December 2014
Americas
The US Court of Appeals for the Federal Circuit has overturned a decision on patent claims for a drug used to treat anorexia and cachexia in AIDS patients. 4 December 2014
Americas
Drugs companies Cipla and Meda Pharmaceuticals have sued Canada-based Apotex as they seek to protect the nasal spray Dymista (Azelastine hydrochloride, fluticasone propionate). 3 December 2014
Asia-Pacific
Japanese drug maker Otsuka Holdings has agreed to buy Avanir Pharmaceuticals as part of a multi-billion dollar deal that could ease its potential patent woes. 2 December 2014
Big Pharma
Nearly 170,000 counterfeit medicinal items have been seized following a police raid in Hungary. 1 December 2014
article
The lights of Oxford and Cambridge University might shine brightest, but there is more than a flicker of success at other academic institutions in the UK. One of those, the University of Manchester, boasts 25 Nobel Prize winners and has housed academic masterminds such as Alan Turing. 28 November 2014
Big Pharma
With its roots stretching back to oil company Shell, Crystallics underpins pharmaceutical research and development by investigating the crystalline structures of drugs and potential drug compounds. LSIPR reports. 28 November 2014
Genetics
Does the coming into force of the Nagoya Protocol represent an overdue step in the right direction towards fairness, or more red tape and unattainable expectations? Charles Brabin, a non-practising barrister, sifts through the complexities. 28 November 2014
Big Pharma
By facilitating public access to the work being done, universities face the challenge of maintaining a balance between being transparent and commercialising IP. LSIPR spoke to the head of the University of Manchester IP about walking the fine line. 28 November 2014
Asia
India has been urged once again to strengthen its IP laws, particularly those covering drugs, following a visit from the US Trade Representative. 27 November 2014